Viewing Study NCT05853835


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2026-01-16 @ 3:49 PM
Study NCT ID: NCT05853835
Status: COMPLETED
Last Update Posted: 2025-01-23
First Post: 2023-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641
Sponsor: LAPIX Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module